New! Rompe Pecho MAX Multi Symptoms, 8 FL. Oz (237 mL) bottle, Distributed by: Efficient Laborato...

FDA Drug Recall #D-0847-2020 — Class II — January 31, 2020

Recall Summary

Recall Number D-0847-2020
Classification Class II — Moderate risk
Date Initiated January 31, 2020
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Efficient Laboratories, Inc.
Location Miami, FL
Product Type Drugs
Quantity 4080 8 FL Oz bottles

Product Description

New! Rompe Pecho MAX Multi Symptoms, 8 FL. Oz (237 mL) bottle, Distributed by: Efficient Laboratories, Inc. Miami, FL 33166. UPC 0 00856 00309 5

Reason for Recall

Microbial Contamination of Non-Sterile Products

Distribution Pattern

Distributed Nationwide in the USA

Lot / Code Information

Lot: 19B42 Exp. February 2022

Other Recalls from Efficient Laboratories, Inc.

Recall # Classification Product Date
D-0293-2022 Class II Rompe Pecho Max Multi-Symptoms Maximum Strength... Aug 24, 2021
D-0292-2022 Class II Rompe Pecho Ex Expectorant, packaged in a) 4 F... Aug 24, 2021
D-0290-2022 Class II Rompe Pecho CF Cold & Flu Advanced Formula, 6 F... Aug 24, 2021
D-0291-2022 Class II Rompe Pecho DM, 6 Fl Oz (178 mL) bottles, Distr... Aug 24, 2021
D-0846-2020 Class II Rompe Pecho EX Expectorant, 6 FL. Oz (178 mL) ... Jan 31, 2020

Frequently Asked Questions

Injectable drugs and eye drops must be completely free of microbial contamination because they bypass the body's natural defenses. A contaminated injectable can introduce bacteria or fungi directly into the bloodstream, potentially causing sepsis, meningitis, or localized infections — all of which can be life-threatening. Contamination of sterile products almost always results in a Class I recall. If you received an injectable drug from a recalled lot, contact your healthcare provider immediately, even if you feel well, as some infections can have delayed onset.

Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications — even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.

Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.

What Should You Do?

Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications — use a drug take-back program.